Jennison Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,403
| Closed | -$1.58M | – | 734 |
|
|
2021
Q2 | $1.58M | Sell |
4,403
-12,941
| -75% | -$4.65M | ﹤0.01% | 576 |
|
|
2021
Q1 | $4.89M | Sell |
17,344
-731
| -4% | -$206K | ﹤0.01% | 471 |
|
|
2020
Q4 | $5.12M | Sell |
18,075
-508
| -3% | -$144K | ﹤0.01% | 449 |
|
|
2020
Q3 | $5.11M | Buy |
18,583
+12,130
| +188% | +$3.33M | ﹤0.01% | 434 |
|
|
2020
Q2 | $1.47M | Buy |
+6,453
| New | +$1.47M | ﹤0.01% | 489 |
|
|
2020
Q1 | – | Sell |
-4,123
| Closed | -$620K | – | 707 |
|
|
2019
Q4 | $620K | Buy |
+4,123
| New | +$620K | ﹤0.01% | 573 |
|
|
2018
Q1 | – | Sell |
-354,164
| Closed | -$34.9M | – | 700 |
|
|
2017
Q4 | $34.9M | Sell |
354,164
-313,859
| -47% | -$31M | 0.03% | 308 |
|
|
2017
Q3 | $64.3M | Buy |
668,023
+236,022
| +55% | +$22.7M | 0.07% | 234 |
|
|
2017
Q2 | $40.8M | Sell |
432,001
-44,310
| -9% | -$4.19M | 0.04% | 294 |
|
|
2017
Q1 | $38.9M | Sell |
476,311
-3,825
| -0.8% | -$312K | 0.04% | 314 |
|
|
2016
Q4 | $40.7M | Buy |
+480,136
| New | +$40.7M | 0.05% | 297 |
|
|
2014
Q3 | – | Sell |
-13,662
| Closed | -$576K | – | 751 |
|
|
2014
Q2 | $576K | Sell |
13,662
-2
| -0% | -$84 | ﹤0.01% | 668 |
|
|
2014
Q1 | $602K | Sell |
13,664
-178
| -1% | -$7.84K | ﹤0.01% | 671 |
|
|
2013
Q4 | $679K | Sell |
13,842
-8,174
| -37% | -$401K | ﹤0.01% | 632 |
|
|
2013
Q3 | $906K | Sell |
22,016
-350
| -2% | -$14.4K | ﹤0.01% | 616 |
|
|
2013
Q2 | $786K | Buy |
+22,366
| New | +$786K | ﹤0.01% | 604 |
|